Can we predict feeding problems in the ICU?

NCT ID NCT07780734

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study looks at why some intensive care unit (ICU) patients have trouble tolerating tube feeding, a common issue that can complicate recovery. Researchers will track 102 adult ICU patients who receive nutrition through a tube, recording any signs of feeding intolerance like vomiting or bloating. They will also collect information on patient characteristics, lab results, and treatments to see which factors are linked to these problems. The goal is to better understand feeding intolerance and its impact on patient outcomes, without adding any extra procedures or treatments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could identify key risk factors for feeding intolerance, helping clinicians tailor nutritional support and potentially improve outcomes for critically ill patients.
What could go wrong
As an observational study, it cannot prove cause and effect. The findings may be specific to this ICU setting and may not apply broadly, and the sample size is modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 102 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population will consist of adult patients aged 18 years or older who are admitted to the Anesthesiology and Reanimation Intensive Care Unit of Ankara Atatürk Sanatoryum Training and Research Hospital and who are started on enteral nutrition. Patients will be prospectively screened and consecutively enrolled if they meet all inclusion criteria and none of the exclusion criteria.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥18 years * Admission to the Anesthesia Intensive Care Unit * Enteral nutrition planned or initiated during intensive care unit admission * Expected to require enteral nutrition during intensive care unit follow-up * Availability of sufficient clinical and nutritional data for study evaluation * Patient or legally authorized representative provides informed consent when required by the ethics protocol Exclusion Criteria: * Age \<18 years * Patients receiving only parenteral nutrition * Patients in whom enteral nutrition is contraindicated throughout the observation period * Patients with insufficient data for evaluation of enteral feeding tolerance * Patients transferred to another intensive care unit before adequate study assessment * Patients who decline participation or whose legally authorized representative declines participation when consent is required

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Patients who receive enteral nutrition for at least 72 hours in the intensive care unit will be included in the study are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.